Denosumab for giant cell tumour of bone: success and limitations-Reference-Cited by-同舟云学术

Denosumab for giant cell tumour of bone: success and limitations

Published:2019-12 Issue:12 Volume:20 Page:1627-1628
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Healey John H

Funder

NIH

Publisher

Elsevier BV

Subject

Oncology

Reference6 articles.

1. Denosumab in patients with giant cell tumour of bone: a multicentre, open-label, phase 2 study;Chawla;Lancet Oncol,2019

2. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study;Chawla;Lancet Oncol,2013

3. Cryosurgery and acrylic cementation as surgical adjuncts in the treatment of aggressive (benign) bone tumors. Analysis of 25 patients below the age of 21;Malawer;Clin Orthop Relat Res,1991

4. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement;O'Donnell;J Bone Joint Surg Am,1994

5. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone?;Gaston;Bone Joint Surg Br,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Spine Tumors;Orthopaedics and Trauma;2024

2. Preoperative denosumab treatment in patients with giant cell bone tumors in limbs: A retrospective study using propensity score matching;Cancer Medicine;2023-05-22

3. Expression of SATB2, RUNX2, and SOX9 and possible osteoblastic and chondroblastic differentiation in chondroblastoma;Pathology - Research and Practice;2023-01

4. Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy;Cancers;2022-11-23

5. Malignant Transformation of Giant Cell Tumor of Bone and the Association with Denosumab Treatment: A Radiology and Pathology Perspective;Sarcoma;2022-06-17